Australia markets closed

Ionis Pharmaceuticals Inc (ISI.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
36.56-0.60 (-1.61%)
At close: 08:02AM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
776,620
787,647
587,367
810,456
729,264
Cost of revenue
9,941
9,133
14,116
10,842
11,947
Gross profit
766,679
778,514
573,251
799,614
717,317
Operating expenses
Research development
916,027
899,625
833,147
643,453
535,077
Selling general and administrative
239,728
232,600
150,300
170,900
332,200
Total operating expenses
1,155,755
1,132,225
983,447
814,353
867,277
Operating income or loss
-389,076
-353,711
-410,196
-14,739
-149,960
Interest expense
80,333
75,597
2,800
4,400
6,200
Total other income/expenses net
111,789
101,222
160,328
-5,013
24,840
Income before tax
-363,750
-333,965
-257,985
-29,148
-134,552
Income tax expense
21,016
32,321
11,737
-551
345,191
Income from continuing operations
-384,766
-366,286
-269,722
-28,597
-479,743
Net income
-384,766
-366,286
-269,722
-28,597
-444,263
Net income available to common shareholders
-384,766
-366,286
-269,722
-28,597
-444,263
Basic EPS
-2.87
-2.56
-1.90
-0.20
-3.18
Diluted EPS
-2.87
-2.56
-1.90
-0.20
-3.18
Basic average shares
142,801
143,190
141,848
141,021
139,612
Diluted average shares
142,801
143,190
141,848
141,021
139,612